These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 29234923)

  • 1. Non-inferiority multicenter prospective randomized controlled study of rectal cancer T
    Serra-Aracil X; Pericay C; Golda T; Mora L; Targarona E; Delgado S; Reina A; Vallribera F; Enriquez-Navascues JM; Serra-Pla S; Garcia-Pacheco JC;
    Int J Colorectal Dis; 2018 Feb; 33(2):241-249. PubMed ID: 29234923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study).
    Serra-Aracil X; Pericay C; Badia-Closa J; Golda T; Biondo S; Hernández P; Targarona E; Borda-Arrizabalaga N; Reina A; Delgado S; Vallribera F; Caro A; Gallego-Plazas J; Pascual M; Álvarez-Laso C; Guadalajara-Labajo HG; Mora-Lopez L
    Ann Oncol; 2023 Jan; 34(1):78-90. PubMed ID: 36220461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol for a multicenter prospective controlled and randomized trial of transanal total mesorectal excision versus laparoscopic low anterior resection in rectal cancer.
    Serra-Aracil X; Zárate A; Mora L; Serra-Pla S; Pallisera A; Bonfill J; Bargalló J; Pando A; Delgado S; Balleteros E; Pericay C
    Int J Colorectal Dis; 2018 May; 33(5):649-655. PubMed ID: 29546560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further evidence for preoperative chemoradiotherapy and transanal endoscopic surgery (TEM) in T2-3s,N0,M0 rectal cancer.
    Pericay C; Serra-Aracil X; Ocaña-Rojas J; Mora-López L; Dotor E; Casalots A; Pisa A; Saigí E
    Clin Transl Oncol; 2016 Jul; 18(7):666-71. PubMed ID: 26497352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of neoadjuvant short-course radiation therapy followed by transanal endoscopic microsurgery for t1-t2 n0 extraperitoneal rectal cancer.
    Arezzo A; Arolfo S; Allaix ME; Munoz F; Cassoni P; Monagheddu C; Ricardi U; Ciccone G; Morino M
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):299-306. PubMed ID: 25772184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy.
    Lezoche E; Baldarelli M; Lezoche G; Paganini AM; Gesuita R; Guerrieri M
    Br J Surg; 2012 Sep; 99(9):1211-8. PubMed ID: 22864880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence.
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Fernandez LM; de Azevedo RU; Vailati BB; Fernandes FA; Gama-Rodrigues J
    Ann Surg Oncol; 2016 Apr; 23(4):1143-8. PubMed ID: 26577119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
    Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
    Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant therapy and transanal endoscopic surgery in T2-T3 superficial, N0, M0 rectal tumors. Local recurrence, complete clinical and pathological response.
    Serra-Aracil X; Pericay C; Mora-Lopez L; Garcia Pacheco JC; Latorraca JI; Ocaña-Rojas J; Casalots A; Ballesteros E; Navarro-Soto S
    Cir Esp; 2017 Apr; 95(4):199-207. PubMed ID: 28411888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study.
    Bach SP; Gilbert A; Brock K; Korsgen S; Geh I; Hill J; Gill T; Hainsworth P; Tutton MG; Khan J; Robinson J; Steward M; Cunningham C; Levy B; Beveridge A; Handley K; Kaur M; Marchevsky N; Magill L; Russell A; Quirke P; West NP; Sebag-Montefiore D;
    Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):92-105. PubMed ID: 33308452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Transanal Endoscopic Microsurgery and Total Mesorectal Excision in the Treatment of T1 Rectal Cancer: A Meta-Analysis.
    Lu JY; Lin GL; Qiu HZ; Xiao Y; Wu B; Zhou JL
    PLoS One; 2015; 10(10):e0141427. PubMed ID: 26505895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review.
    Allaix ME; Arezzo A; Morino M
    Surg Endosc; 2016 Nov; 30(11):4841-4852. PubMed ID: 26902614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing neoadjuvant therapy followed by local excision to total mesorectal excision in the treatment of early stage rectal cancer: a systematic review and meta-analysis of randomised clinical trials.
    Lynch P; Ryan OK; Donnelly M; Ryan ÉJ; Davey MG; Reynolds IS; Creavin B; Hanly A; Kennelly R; Martin ST; Winter DC
    Int J Colorectal Dis; 2023 Nov; 38(1):263. PubMed ID: 37924372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention.
    De Graaf EJ; Doornebosch PG; Tollenaar RA; Meershoek-Klein Kranenbarg E; de Boer AC; Bekkering FC; van de Velde CJ
    Eur J Surg Oncol; 2009 Dec; 35(12):1280-5. PubMed ID: 19487099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients.
    Law WL; Chu KW
    Ann Surg; 2004 Aug; 240(2):260-8. PubMed ID: 15273550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.
    Kitz J; Fokas E; Beissbarth T; Ströbel P; Wittekind C; Hartmann A; Rüschoff J; Papadopoulos T; Rösler E; Ortloff-Kittredge P; Kania U; Schlitt H; Link KH; Bechstein W; Raab HR; Staib L; Germer CT; Liersch T; Sauer R; Rödel C; Ghadimi M; Hohenberger W;
    JAMA Surg; 2018 Aug; 153(8):e181607. PubMed ID: 29874375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer.
    Marks JH; Myers EA; Zeger EL; Denittis AS; Gummadi M; Marks GJ
    Surg Endosc; 2017 Dec; 31(12):5248-5257. PubMed ID: 28643051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial.
    Rullier E; Rouanet P; Tuech JJ; Valverde A; Lelong B; Rivoire M; Faucheron JL; Jafari M; Portier G; Meunier B; Sileznieff I; Prudhomme M; Marchal F; Pocard M; Pezet D; Rullier A; Vendrely V; Denost Q; Asselineau J; Doussau A
    Lancet; 2017 Jul; 390(10093):469-479. PubMed ID: 28601342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.